α4 was the first integrin explored as a potential target for the management of UC and CD, and as a common subunit of α4β1 and α4β7, HP1/2 (an anti-α4 mAb) significantly alleviated acute colitis in a cotton-top tamarin spontaneous colitis model [110]. The gene discussed is SGCG; the disease is colitis.